Plasma phosphorylated tau 181 (P-tau181) and 217 (P-tau217) are indicators of both amyloid
and tau pathology in clinical settings, but their performance in heterogeneous community-…

Introduction We examined and compared plasma phospho-tau181 (pTau181) and total tau: (1)
across the Alzheimer's disease (AD) clinical spectrum; (2) in relation to brain amyloid β (…

With the aging of the population, the burden of Alzheimer’s disease (AD) is rapidly expanding.
More than 5 million people in the US alone are affected with AD and this number is …

Importance Cerebrospinal fluid phosphorylated tau (p-tau) 181, p-tau217, and p-tau231 are
associated with neuropathological outcomes, but a comparison of these p-tau isoforms in …

Objective: To examine the longitudinal association between plasma total cholesterol and
triglyceride levels and incident dementia. Methods: Neuropsychiatric, anthropometric, …

Background. The association between gait speed and cognition has been reported; however,
there is limited knowledge about the temporal associations between gait slowing and …

There is increasing evidence that subjective cognitive decline (SCD) in individuals with
unimpaired performance on cognitive tests may represent the first symptomatic manifestation of …

For many years, blood-based biomarkers for Alzheimer's disease seemed unattainable, but
recent results have shown that they could become a reality. Convincing data generated with …

BACKGROUND: Diffusion tensor imaging (DTI) studies have shown significant cross-sectional
differences among normal controls (NC) mild cognitive impairment (MCI) and Alzheimer's …

Alzheimer’s disease (AD) dementia is the most common form of dementia, comprising 60 to
70 percent of all cases. AD is a progressive neurodegenerative disease that causes memory …